Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M. S. Sayapina"'
Autor:
M. S. Sayapina, S. G. Averinova, T. V. Zacharova, A. V. Kashkadaeva, S. V. Shiryaev, M. V. Poluectova, O. A. Vorob’eva
Publikováno v:
International Journal of Nephrology, Vol 2017 (2017)
Study Objective. To study the effectiveness of complex monitoring of the kidney function, based on biochemical and radionuclide methods in patients with metastatic renal cell carcinoma (mRCC). Materials and Methods. 41 mRCC patients after nephrectomy
Externí odkaz:
https://doaj.org/article/b3076dd9b4ec4c0087fb3c39e0029f03
Publikováno v:
Onkourologiâ, Vol 14, Iss 1, Pp 16-27 (2018)
Background. Therapy with immune checkpoint inhibitors (antibodies against PD-1) has become a standard of treatment of patients with metastatic renal cell carcinoma (mRCC) resistant to tyrosine kinase inhibitors. Objective: to identify reliable immuno
Autor:
S. N. Sayapin, M. S. Sayapina
Publikováno v:
Biomedical Engineering. 51:147-151
A new concept design for a multifunctional self-moving cup massager based on an active triangular module of parallel structure is presented. The design principles and functional capacities of the massager, which provides for automated sliding cup mas
Publikováno v:
Russian Journal of Biotherapy. 16:91-96
Publikováno v:
Onkourologiâ, Vol 12, Iss 4, Pp 35-42 (2016)
In the article a new alternating regimen which includes alternation between interferon (INF) immunotherapy and target therapy (sunitinib) is described through a clinical case. Mentions of this type of regimen weren’t found in the literature. As a r
Autor:
M. I. Volkova, D. A. Nosov, V. A. Chernyaev, E. A. Voroshilova, M. S. Sayapina, G. P. Kolesnikov, R. V. Leonenkov, D. A. Khvorostenko, P. S. Borisov, M. U. Shushakov, N. V. Kirdakova, B. Ya. Alekseev, M. G. Matyash
Publikováno v:
Onkourologiâ, Vol 12, Iss 2, Pp 18-27 (2016)
Objective – to evaluate efficacy and safety of everolimus in Russian population of unselected patients with advanced renal cell carcinoma progressing after at least 1 line of anti-angiogenic targeted therapy. Materials and methods . In observationa
Publikováno v:
Onkourologiâ, Vol 10, Iss 3, Pp 12-21 (2014)
The application of targeted and pathogenetically sound medicational approaches could considerably improve the results of therapy in patients with metastatic renal-cell carcinoma (mRCC). To date, VEGF/VEGFR inhibitors continue to remain a basic and mo
Publikováno v:
Onkourologiâ, Vol 9, Iss 3, Pp 37-42 (2014)
With the clinical introduction of targeted drugs, the results of therapy in patients with metastatic renal-cell carcinoma (mRCC) of all prognostic groups as witnessed by the data of randomized trials. Nevertheless, there is a group of favorable progn